
Ongoing trials
Participation in therapeutic trials (“research protocols”) allows patients to benefit from therapeutic innovations currently being validated.
These studies are subject to multiple validations guaranteeing their scientific interest and respect for ethics, before being offered to patients.
The main open drug trials are:
- ROCSAN: addition of immunotherapy and a PARP inhibitor for the treatment of recurrent carcinosarcoma,
- UTOLA: use of olaparib in endometrial cancer recurrences